有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-[(1R)-1-(4-chlorophenyl)ethyl]-2-[(5-cyclopropyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C18H21ClN4OS |
|
—— | N-[(1S,2S,3S)-2,3-dimethylcyclohexyl]-2-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C16H26N4OS |
|
—— | 2-[[5-cyclopropyl-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]-N-[[(2R)-oxolan-2-yl]methyl]acetamide | —— | C17H22N4O3S |
|
—— | N-[(1S)-1-(4-chlorophenyl)ethyl]-2-[(5-cyclopropyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C18H21ClN4OS |
|
—— | N-[(1R,2S,3R)-2,3-dimethylcyclohexyl]-2-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C16H26N4OS |
|
—— | (1S)-1-[4-butyl-5-[[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine | —— | C20H27ClN6OS |
|
—— | N-[(1R)-1-(4-chlorophenyl)ethyl]-2-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C16H19ClN4OS |
|
—— | N-[(1S)-1-(4-chlorophenyl)ethyl]-2-[[5-(2-methylfuran-3-yl)-4-prop-2-enyl-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C20H21ClN4O2S |
|
—— | 2-[[4-butyl-5-[(1S)-1-(dimethylamino)propyl]-1,2,4-triazol-3-yl]sulfanyl]-N-methylacetamide | —— | C14H27N5OS |
|
—— | N-[(1S,2S,3R)-2,3-dimethylcyclohexyl]-2-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C16H26N4OS |
|
—— | N-[(1S)-1-(4-chlorophenyl)ethyl]-2-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C16H19ClN4OS |
|
—— | 2-[[4-butyl-5-[(1R)-1-(dimethylamino)propyl]-1,2,4-triazol-3-yl]sulfanyl]-N-methylacetamide | —— | C14H27N5OS |
|
—— | (2R)-N-(1-cyanocyclohexyl)-2-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]propanamide | —— | C16H23N5OS |
|
—— | (2R)-2-[[4-benzyl-5-(5-bromofuran-2-yl)-1,2,4-triazol-3-yl]sulfanyl]cyclohexan-1-one | —— | C19H18BrN3O2S |
|
—— | (2S)-2-[[4-benzyl-5-(5-bromofuran-2-yl)-1,2,4-triazol-3-yl]sulfanyl]cyclohexan-1-one | —— | C19H18BrN3O2S |
|
—— | (2R)-2-[[5-[4-(difluoromethylsulfanyl)anilino]-1,3,4-thiadiazol-2-yl]sulfanyl]cyclohexan-1-one | —— | C15H15F2N3OS3 |
|
—— | (S)-cyclohexyl-[4-(trifluoromethylsulfanyl)phenyl]methanol | —— | C14H17F3OS |
|
—— | (2S)-2-[[5-[4-(difluoromethylsulfanyl)anilino]-1,3,4-thiadiazol-2-yl]sulfanyl]cyclohexan-1-one | —— | C15H15F2N3OS3 |
|
—— | 3-[[(5-bromofuran-2-yl)methyl-methylamino]methyl]-5-methylsulfanyl-1,3,4-thiadiazole-2-thione | —— | C10H12BrN3OS3 |
|
—— | N-[(1R,2R,3R)-2,3-dimethylcyclohexyl]-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C13H21N3OS3 |
|
—— | N-[(1R)-1-(4-chlorophenyl)ethyl]-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C13H14ClN3OS3 |
|
—— | (R)-cyclohexyl-[4-(trifluoromethylsulfanyl)phenyl]methanol | —— | C14H17F3OS |
|
—— | (R)-cyclopentyl-[4-(trifluoromethylsulfanyl)phenyl]methanol | —— | C13H15F3OS |
|
—— | (2S)-N-(1-cyanocyclohexyl)-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C13H18N4OS3 |
|
—— | N-[(1S)-1-(4-chlorophenyl)ethyl]-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C13H14ClN3OS3 |
|
—— | (S)-cyclopentyl-[4-(trifluoromethylsulfanyl)phenyl]methanol | —— | C13H15F3OS |
|
—— | N-[(1S,2R,3S)-2,3-dimethylcyclohexyl]-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C13H21N3OS3 |
|
—— | N-[(1S,2R,3R)-2,3-dimethylcyclohexyl]-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C13H21N3OS3 |
|
—— | (2R)-N-(1-cyanocyclohexyl)-2-[(5-methylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C13H18N4OS3 |
|
—— | 2-(4,6-dimethylpyrimidin-2-yl)sulfanyl-N-[(2R)-4-phenylbutan-2-yl]acetamide | —— | C18H23N3OS |
|
—— | (2R)-N-[(1R,2R,3S)-2,3-dimethylcyclohexyl]-2-phenylsulfanylpropanamide | —— | C17H25NOS |
|
—— | N-[(1R)-1-(4-chlorophenyl)ethyl]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamide | —— | C16H18ClN3OS |
|
—— | (2R)-N-[(1S,2R,3S)-2,3-dimethylcyclohexyl]-2-phenylsulfanylpropanamide | —— | C17H25NOS |
|
—— | 2-(4,6-dimethylpyrimidin-2-yl)sulfanyl-N-[(2S)-4-phenylbutan-2-yl]acetamide | —— | C18H23N3OS |
|
—— | N-[(1S)-1-(4-chlorophenyl)ethyl]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamide | —— | C16H18ClN3OS |
|
—— | (2R)-N-[(1R,2R,3R)-2,3-dimethylcyclohexyl]-2-phenylsulfanylpropanamide | —— | C17H25NOS |
|
—— | 4-[2-(4-Chlorophenyl)sulfanylethyl]morpholin-4-ium | —— | C12H17ClNOS+ |
|
—— | 1-[3-(4-Chlorophenyl)sulfanylpropyl]-4-methylpiperazine-1,4-diium | —— | C14H23ClN2S+2 |
|
—— | ethyl (3S)-1-[2-(4-bromophenyl)sulfanylpyridine-3-carbonyl]piperidine-3-carboxylate | —— | C20H21BrN2O3S |
|
—— | (2S)-N-[(4-ethylcyclohexyl)methyl]-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]propanamide | —— | C15H26N4OS |
|
—— | (2R,6S)-2,6-dimethyl-4-(2-phenylsulfanylethyl)morpholin-4-ium | —— | C14H22NOS+ |
|
—— | (2R,6R)-2,6-dimethyl-4-(2-phenylsulfanylethyl)morpholine | —— | C14H21NOS |
|
—— | (2R,6S)-2,6-dimethyl-4-(2-phenylsulfanylethyl)morpholine | —— | C14H21NOS |
|
—— | 2-(4-methylphenyl)sulfanylethyl-[[(2S)-oxolan-2-yl]methyl]azanium | —— | C14H22NOS+ |
|
—— | (2R,6R)-2,6-dimethyl-4-(2-phenylsulfanylethyl)morpholin-4-ium | —— | C14H22NOS+ |
|
—— | (2S,6S)-2,6-dimethyl-4-(2-phenylsulfanylethyl)morpholin-4-ium | —— | C14H22NOS+ |
|
—— | 4-[4-(4-Methylphenyl)sulfanylbutyl]morpholin-4-ium | —— | C15H24NOS+ |
|
—— | (2S,6S)-2,6-dimethyl-4-(2-phenylsulfanylethyl)morpholine | —— | C14H21NOS |
|
—— | (2R,6S)-2,6-dimethyl-4-[2-(4-methylphenyl)sulfanylethyl]morpholin-4-ium | —— | C15H24NOS+ |
|
—— | 4-[3-(4-Methylphenyl)sulfanylpropyl]morpholin-4-ium | —— | C14H22NOS+ |
|